These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Shedding of Ann Arbor strain live attenuated influenza vaccine virus in children 6-59 months of age. Mallory RM, Yi T, Ambrose CS. Vaccine; 2011 Jun 10; 29(26):4322-7. PubMed ID: 21513761 [Abstract] [Full Text] [Related]
3. Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults. King JC, Treanor J, Fast PE, Wolff M, Yan L, Iacuzio D, Readmond B, O'Brien D, Mallon K, Highsmith WE, Lambert JS, Belshe RB. J Infect Dis; 2000 Feb 10; 181(2):725-8. PubMed ID: 10669363 [Abstract] [Full Text] [Related]
5. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma. Fleming DM, Crovari P, Wahn U, Klemola T, Schlesinger Y, Langussis A, Øymar K, Garcia ML, Krygier A, Costa H, Heininger U, Pregaldien JL, Cheng SM, Skinner J, Razmpour A, Saville M, Gruber WC, Forrest B, CAIV-T Asthma Study Group. Pediatr Infect Dis J; 2006 Oct 10; 25(10):860-9. PubMed ID: 17006278 [Abstract] [Full Text] [Related]
6. Immunogenicity and safety of a quadrivalent live attenuated influenza vaccine in children. Block SL, Falloon J, Hirschfield JA, Krilov LR, Dubovsky F, Yi T, Belshe RB. Pediatr Infect Dis J; 2012 Jul 10; 31(7):745-51. PubMed ID: 22466322 [Abstract] [Full Text] [Related]